John K Clarke's Net Worth

$5.08 Million

Estimate Recalculated Nov 8, 2024 04:38PM EST

Who is John K Clarke?

John K Clarke has an estimated net worth of $5.08 Million. This is based on reported shares across multiple companies, which include ALNYLAM PHARMACEUTICALS INC, VISICU INC, Sirtris Pharmaceuticals, Inc., Verastem, Inc., aTYR PHARMA INC, MOMENTA PHARMACEUTICALS INC, CUBIST PHARMACEUTICALS INC, and ATHENAHEALTH INC.

SEC CIK

John K Clarke's CIK is 0001219015

Past Insider Trading and Trends

2005 was John K Clarke's most active year for acquiring shares with 8 total transactions. John K Clarke's most active month to acquire stocks was the month of May. 2014 was John K Clarke's most active year for disposing of shares, totalling 7 transactions. John K Clarke's most active month to dispose stocks was the month of April. 2018 saw John K Clarke paying a total of $409,200.00 for 44,000 shares, this is the most they've acquired in one year. In 2014 John K Clarke cashed out on 70,000 shares for a total of $1,882,978.90, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ALNYLAM PHARMACEUTICALS INC (ALNY) Snapshot price: $246.78

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 20
Form 4
—
0
$63.80
-$1,095,477.90
8.89K
Scheduled
May 31
Form 4
—
0
—
—
0
Jun 2
Form 4
—
0
—
—
0
Jun 3
Form 4
—
0
—
—
0
Jun 1
Form 4
—
0
—
—
0
Jun 5
Form 4
—
0
$33.42
-$1,426,128.90
0
Scheduled
May 21
Form 4
—
0
—
—
0
Jun 6
Form 4
—
0
—
—
0
Jun 21
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Jun 2
Form 4
—
0
—
—
0
Jun 11
Form 4
—
0
—
—
0
Jun 3
Form 4
—
0
—
—
0
Jun 1
Form 4
—
0
—
—
0
Jun 1
Form 4
—
0
—
—
0
Jun 8
Form 4
+799.73%
1.86M
—
—
2.09M
Jun 3
Form 4
∞
232.5K
—
—
232.5K
May 27
Form 3
—
0
—
—
0
No matching records found

VISICU INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-3.40M
$12.00
-$40,775,076.00
0
Feb 20
Form 4
—
0
—
—
0
Apr 4 - Jul 26
Form 4
-10.36%
-387.00K
$10.04
-$3,884,381.80
3.35M
Nov 30
Form 4
-0.31%
-31.50K
$10.04
-$316,200.00
10.23M
Nov 16
Form 4
∞
3.77M
—
—
3.77M
Apr 10
Form 3
—
0
—
—
0
No matching records found

Sirtris Pharmaceuticals, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
2.07M
—
—
2.07M
May 29
Form 3
—
0
—
—
0
No matching records found

Verastem, Inc. (VSTM) Snapshot price: $2.44

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+1.00%
23.17K
$9.60
$222,425.38
2.33M
Jun 12
Form 4
+1.10%
25K
$9.22
$230,477.50
2.31M
Jun 11
Form 4
—
0
—
—
0
Jun 4
Form 4
+1.11%
25K
$9.74
$243,375.00
2.28M
Scheduled
May 13
Form 4
+0.45%
10K
$9.66
$96,622.00
2.26M
Scheduled
May 1
Form 4
+0.25%
5.63K
$9.50
$53,488.87
2.25M
Apr 17
Form 4
+0.28%
6.19K
$7.87
$48,738.91
2.24M
Scheduled
Dec 18
Form 4
—
0
—
—
0
Mar 6
Form 4
∞
2.23M
$10.00
—
2.23M
Feb 1
Form 3
—
0
—
—
0
No matching records found

aTYR PHARMA INC (LIFE) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 22
Form 4
—
0
—
—
0
May 17
Form 4
+43.49%
6K
—
—
19.8K
Apr 26
Form 4
—
0
—
—
0
Apr 26
Form 4
-2.26%
-2.50K
$4.34
-$10,850.00
108.08K
May 21
Form 4
—
0
—
—
0
Apr 28
Form 4
-6.24%
-7.36K
$4.01
-$29,512.60
110.58K
Aug 28 - Sep 2
Form 4
-6.08%
-7.64K
$4.15
-$31,700.80
117.94K
Aug 26 - Aug 27
Form 4
—
0
—
—
0
May 6
Form 4
—
0
—
—
0
May 8
Form 4
—
0
—
—
0
May 15
Form 4
—
0
—
—
0
May 9
Form 4
—
0
—
—
0
May 24
Form 4
—
0
—
—
0
Jan 27
Form 4
—
0
—
—
0
Jul 8
Form 4
+14,718.93%
1.85M
—
—
1.86M
May 12
Form 3
—
0
—
—
0
No matching records found